Production & Manufacturing
Manufacturing

Manufacturing

WuXi STA, Antengene sign drug development and manufacturing deal STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec, and Antengene have entered into a partnership for the CMC development and manufacturing of innovative oncology drugs.
Production & Manufacturing > Manufacturing > News
EUSA Pharma to buy global rights of Janssen’s Sylvant for $115m By PBR Staff Writer
UK-based EUSA Pharma has agreed to acquire the global rights of Sylvant (siltuximab), a rare blood disorder drug, from Janssen Sciences Ireland UC for $115m.
Production & Manufacturing > Manufacturing > News Clinigen acquires global rights to Proleukin outside US Clinigen Group has acquired the global rights to Proleukin (aldesleukin, recombinant interleukin-2) outside the United States from Novartis.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight